Phio Pharmaceuticals Corp. (PHIO:NASDAQ) soared at $2.6, a gain of 91.2%. On Wed, Oct 11, 2023, PHIO:NASDAQ touched a New 2-Week High of $2.6. From Wed, Sep 27, 2023, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Tue, Apr 18, 2023 at $12.27 with a volume of 5M+.
About Phio Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Top 10 Gainers:
- Tempest Therapeutics Inc. (TPST:NASDAQ), 2879.17%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 313.55%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 91.18%
- Tupperware Brands Corporation (TUP:NYSE), 55.33%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSEMKT), 54.44%
- Athena Consumer Acquisition Corp. Class A (ACAQ:NYSE), 54.44%
- Asset Entities Inc. (ASST:NASDAQ), 45%
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 41.3%
- Bird Global Inc. Class A (BRDS:NYSE), 34.44%
- voxeljet AG (VJET:NASDAQ), 33.98%